11-hydroxyandrostenedione has been researched along with finasteride in 1 studies
Studies (11-hydroxyandrostenedione) | Trials (11-hydroxyandrostenedione) | Recent Studies (post-2010) (11-hydroxyandrostenedione) | Studies (finasteride) | Trials (finasteride) | Recent Studies (post-2010) (finasteride) |
---|---|---|---|---|---|
83 | 2 | 16 | 2,514 | 405 | 867 |
Protein | Taxonomy | 11-hydroxyandrostenedione (IC50) | finasteride (IC50) |
---|---|---|---|
Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Homo sapiens (human) | 0.295 | |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Rattus norvegicus (Norway rat) | 0.0109 | |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Homo sapiens (human) | 0.0131 | |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Rattus norvegicus (Norway rat) | 0.3286 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imperato-McGinley, J; Orlic, S; Shackleton, C; Stoner, E | 1 |
1 trial(s) available for 11-hydroxyandrostenedione and finasteride
Article | Year |
---|---|
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androstenedione; Androstenes; Androsterone; Azasteroids; Corticosterone; Dihydrotestosterone; Disorders of Sex Development; Etiocholanolone; Finasteride; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Liver; Luteinizing Hormone; Male; Middle Aged; Prostatic Hyperplasia; Radioimmunoassay; Randomized Controlled Trials as Topic; Steroids, Heterocyclic; Testosterone | 1990 |